Hidradenitis Suppurativa News

Comorbidities, health care utilization and costs are increasing for patients with hidradenitis suppurativa, prompting a need for better disease management, according to a study.

In a panel-led project, 23 experts created a comprehensive guide for the long-term management of inflammatory skin diseases in pediatric patients treated with methotrexate.

Pediatric patients with hidradenitis suppurativa are more than four times more likely to have Crohn’s disease compared with those without hidradenitis suppurativa, according to a study.

Increased adalimumab dosage may improve disease severity in patients with overweight or obesity with moderate to severe hidradenitis suppurativa, according to a study.

Patients with hidradenitis suppurativa saw improvement with fostamatinib treatment, showing that targeting B cells and plasma cells could be an upcoming strategy in treating the disease, according to a study.

The European Commission has approved Cosentyx in the European Union for the treatment of moderate to severe hidradenitis suppurativa in adults who do not respond to conventional therapy, Novartis announced in a press release.

The FDA has approved Celltrion USA’s Yuflyma as the ninth biosimilar to adalimumab for all eligible indications of the reference product, and the latest in a flood of biosimilars cleared for 2023 release in the United States.

A novel treatment paradigm was associated with improved disease severity and patient satisfaction compared with standard of care in a cohort of patients with hidradenitis suppurativa, according to a study.

The hidradenitis suppurativa-IGA score strongly correlated with other measures of the condition’s activity and may be more useful for clinicians, according to a study.

Adalimumab accompanied by surgery significantly out-performed adalimumab monotherapy in the treatment of patients with moderate to severe hidradenitis suppurativa, according to a study.